CRIS Current Research Information System

NICOLETTI, GIORDANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.742
AS - Asia 1.894
EU - Europa 1.631
AF - Africa 142
SA - Sud America 97
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.701
VN - Vietnam 622
SG - Singapore 488
GB - Regno Unito 439
CN - Cina 438
DE - Germania 220
IT - Italia 201
SE - Svezia 163
HK - Hong Kong 136
FR - Francia 112
UA - Ucraina 98
RU - Federazione Russa 93
IN - India 73
CH - Svizzera 71
BR - Brasile 65
IE - Irlanda 55
CI - Costa d'Avorio 46
JP - Giappone 38
ZA - Sudafrica 37
EE - Estonia 35
TG - Togo 34
NL - Olanda 32
CA - Canada 27
FI - Finlandia 27
BE - Belgio 20
BG - Bulgaria 20
AR - Argentina 14
PH - Filippine 12
JO - Giordania 10
KR - Corea 10
MX - Messico 10
PL - Polonia 10
SC - Seychelles 10
TH - Thailandia 10
RO - Romania 9
ID - Indonesia 8
IQ - Iraq 7
LT - Lituania 7
PK - Pakistan 7
BD - Bangladesh 6
TR - Turchia 6
CL - Cile 5
EC - Ecuador 5
NG - Nigeria 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EG - Egitto 4
HR - Croazia 4
IR - Iran 4
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 3
GR - Grecia 3
AT - Austria 2
DO - Repubblica Dominicana 2
KE - Kenya 2
KH - Cambogia 2
MY - Malesia 2
PE - Perù 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
JM - Giamaica 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 6.512
Salva come PNG Salva come JPEG
Città #
Southend 367
Singapore 338
Fairfield 321
Ashburn 314
Chandler 286
Wilmington 153
Ann Arbor 143
Houston 134
Woodbridge 134
Hong Kong 133
Seattle 130
Ho Chi Minh City 122
Hanoi 101
Cambridge 99
San Jose 91
Dong Ket 81
Santa Clara 80
Princeton 77
Jacksonville 65
Beijing 61
Bern 61
Dublin 55
Boardman 52
Abidjan 46
Nanjing 40
Westminster 36
Lauterbourg 35
Lomé 34
Padova 34
Bologna 32
Tokyo 32
Los Angeles 29
Bremen 27
Berlin 26
Helsinki 25
Guangzhou 23
Jinan 23
Saint Petersburg 23
Haiphong 22
San Diego 22
Brussels 20
Sofia 20
Dallas 19
Shenyang 19
Hebei 18
Hefei 17
Falkenstein 16
Buffalo 15
Da Nang 15
Nanchang 14
New York 14
Redwood City 14
London 13
Milan 13
Ottawa 13
Changsha 11
Des Moines 11
Frankfurt am Main 11
Redondo Beach 11
Tianjin 11
Zhengzhou 11
Amman 10
Mülheim 10
Phoenix 10
São Paulo 10
Turin 10
Mahé 8
Atlanta 7
Dearborn 7
Toronto 7
Verona 7
Warsaw 7
Amsterdam 6
Biên Hòa 6
Casalecchio di Reno 6
Chicago 6
Council Bluffs 6
Jiaxing 6
Quận Ba 6
Taiyuan 6
Taizhou 6
Fuzhou 5
Haikou 5
Hải Dương 5
Johannesburg 5
Paris 5
Sassuolo 5
Seoul 5
Yubileyny 5
Abeokuta 4
Barnet 4
Boston 4
Bulle 4
Bình Phước 4
Bühl 4
Can Tho 4
Hangzhou 4
Islamabad 4
Jakarta 4
Kuban 4
Totale 4.444
Salva come PNG Salva come JPEG
Nome #
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 264
Development of a K-edge micro CT for the study of tumor angiogenesis in small animals 246
Virus-like particle display of HER2 induces potent anti-cancer responses 229
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 226
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 224
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 216
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 209
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 200
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 199
In silico modeling and in vivo efficacy of cancer preventive vaccinations 196
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function 190
Antimetastatic activity of a preventive cancer vaccine. 185
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 184
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 184
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 184
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 176
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 175
Modeling the competition between lung metastases and the immune system using agents. 175
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 175
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 175
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis 173
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 170
Immunoprevention and immunotherapy of mammary carcinoma 170
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 169
Translational immunomics of cancer prevention. 162
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. 161
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 160
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 158
NVE-BEZ235 as a new therapeutic option for sarcomas. 155
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 146
null 145
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 145
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 144
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 142
Molecular and cellular biology of rhabdomyosarcoma 140
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 139
Characterization of Biological Tissues using X-ray Attenuation Data 120
Totale 6.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 23 24 175
2021/2022796 99 20 66 32 61 39 20 45 30 55 198 131
2022/2023991 113 133 65 150 45 65 25 57 125 39 77 97
2023/2024199 6 39 12 23 18 39 16 11 6 15 4 10
2024/2025762 60 82 61 37 160 47 38 25 5 49 29 169
2025/20261.611 133 109 139 131 226 106 150 47 433 137 0 0
Totale 6.611